Fineotex Chemical Limited — PPTs, 14-02-2025: Investor Presentation

**Financial Highlights:** Fineotex Chemical Limited reported revenue from operations of ₹125.92 crore for Q3 FY25, down from ₹138.45 crore YoY, while total revenue declined by 8.7% to ₹130.91 crore. EBITDA stood at ₹34.29 crore (27.23% margin), compared to ₹40.35 crore (29.15% margin) for Q3 FY24. Profit After Tax (PAT) was ₹27.83 crore, with a margin of 22.10%, reflecting a decrease from ₹32.93 crore (23.78% margin) in the same period last year.

**Strategic Initiatives and Growth Drivers:** The company is expanding its production capacity with a new 7-acre facility in Ambernath, expected to contribute an additional 15,000 MTPA by Q2 FY26. Fineotex aims for innovation, with 15 new products developed in Q3 FY25. Strong order pipeline across new sectors like oil & gas and water treatment supports growth.

**Business Developments:** Fineotex added 30 new customers in the textiles segment during Q3 FY25, indicating robust demand fundamentals despite some postponements. Their joint operations with HealthGuard and strategic collaborations with organizations like Sasmira and Eurodye aim to enhance sustainable chemistry offerings.

**Market Position and Competitive Advantage:** The company is a leading player in specialty chemicals across textiles and cleaning sectors, leveraging R&D strengths from Biotex in Malaysia. A focus on sustainability and eco-friendly solutions aligns with growing market trends, positioning Fineotex for future growth.

**Investor Implications:** Despite current challenges in FMCG demand, the outlook remains positive, with the anticipated benefits from new capacities and product lines. The upcoming initiatives in water treatment and oil & gas content to penetrate new markets, presenting solid growth potential for shareholders.